Home/Publication/Anthem, a CDMO, Debuts on India’s Stock Exchanges
Anthem, a CDMO, Debuts on India’s Stock Exchanges 

21 Jul 2025

US$ 20.00

Anthem Biosciences Ltd (Anthem), a contract development and manufacturing organisation backed by True North and ......

Price / article: US$20.00
OR existing subscriber
Related Publications

EQT AB announced that its Asia-focused fund, BPEA Private Equity Fund IX (BPEA IX), has raised US$11.4 bn. Of this ......

Gaorong Ventures, Neovision Capital and Baheal Zhongxin Capital have co-led the over US$100 m financing round ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.